Advanced Assessment of Hepatic Choline and Lipid Profiling via Magnetic Resonance Spectroscopy among Young Saudi Women: Unraveling Metabolic Dynamics and Implications for Health

ORIGINAL ARTICLE
Halima Hawesa

 
For citation: Hawesa H. Advanced Assessment of Hepatic Choline and Lipid Profiling via Magnetic Resonance Spectroscopy among Young Saudi Women: Unraveling Metabolic Dynamics and Implications for Health. International Journal of Biomedicine. 2024;14(3):478-483. doi:10.21103/Article14(3)_OA15
 
Originally published September 6, 2024

Abstract: 

Background: Choline, a vital nutrient, and lipids play pivotal roles in liver function and overall metabolic homeostasis. Magnetic resonance spectroscopy (MRS) offers a non-invasive and highly sensitive method for assessing hepatic choline and lipid levels in vivo. This study aims to investigate the correlation between liver choline and lipid levels among young Saudi women.
Methods and Results: This cross-sectional research explored the relationship between liver choline and fat levels, employing MRS to estimate these levels. A total of 29 healthy female students from the radiological sciences department, aged between 18 and 25 years, participated in the study. MRS scans were conducted using a 1.5 tesla Philips scanner using single volume sequence (SVS). The SVS spectroscopy sequence used in this study indicated the presence of lipid peaks within the frequency range of 0.9-1.2 ppm and choline peaks at 3.2 ppm. The Pearson correlation test revealed a statistically significant association between choline and lipid levels in the liver (r=0.367, P=0.025).
Conclusion: Investigating the relationship between liver lipids and choline levels is crucial for understanding liver health, identifying metabolic dysregulation, informing diagnostic and therapeutic strategies, promoting personalized medicine, and advancing scientific research in the field of metabolism and liver diseases.

Keywords: 
liver • lipids • choline • MRS • SVS
References: 
  1. Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutr Rev. 1994 Oct;52(10):327-39. doi: 10.1111/j.1753-4887.1994.tb01357.x. PMID: 7816350.
  2. Mehedint MG, Zeisel SH. Choline's role in maintaining liver function: new evidence for epigenetic mechanisms. Curr Opin Clin Nutr Metab Care. 2013 May;16(3):339-45. doi: 10.1097/MCO.0b013e3283600d46. PMID: 23493015; PMCID: PMC3729018.
  3. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229-50. doi: 10.1146/annurev.nutr.26.061505.111156. PMID: 16848706; PMCID: PMC2441939.
  4. Cho E, Willett WC, Colditz GA, Fuchs CS, Wu K, Chan AT, Zeisel SH, Giovannucci EL. Dietary choline and betaine and the risk of distal colorectal adenoma in women. J Natl Cancer Inst. 2007 Aug 15;99(16):1224-31. doi: 10.1093/jnci/djm082. Epub 2007 Aug 8. PMID: 17686825; PMCID: PMC2441932.
  5. Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, Berger A, Jia W, Zeisel SH. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J. 2010 Aug;24(8):2962-75. doi: 10.1096/fj.09-154054. Epub 2010 Apr 6. PMID: 20371621; PMCID: PMC2909293.
  6. Öz G, Deelchand DK, Wijnen JP, Mlynárik V, Xin L, Mekle R, Noeske R, Scheenen TWJ, Tkáč I; Experts' Working Group on Advanced Single Voxel 1H MRS. Advanced single voxel 1 H magnetic resonance spectroscopy techniques in humans: Experts' consensus recommendations. NMR Biomed. 2020 Jan 10:e4236. doi: 10.1002/nbm.4236. Epub ahead of print. PMID: 31922301; PMCID: PMC7347431.
  7. Zhu J, Wu Y, Tang Q, Leng Y, Cai W. The effects of choline on hepatic lipid metabolism, mitochondrial function and antioxidative status in human hepatic C3A cells exposed to excessive energy substrates. Nutrients. 2014 Jul 9;6(7):2552-71. doi: 10.3390/nu6072552. PMID: 25010553; PMCID: PMC4113756.
  8. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 2005 Jan;54(1):122-7. doi: 10.1136/gut.2003.036566. PMID: 15591516; PMCID: PMC1774370.
  9. Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, Hong KC, Kim YB, Lee JH, Suh CH. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology. 2001 Dec;221(3):740-6. doi: 10.1148/radiol.2213010106. PMID: 11719670.
  10. Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012 Mar;28(2):159-65. doi: 10.1097/MOG.0b013e32834e7b4b. PMID: 22134222; PMCID: PMC3601486.
  11. Teodoro JS, Rolo AP, Duarte FV, Simões AM, Palmeira CM. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion. 2008 Dec;8(5-6):367-76. doi: 10.1016/j.mito.2008.07.008. Epub 2008 Aug 15. PMID: 18765303.
  12. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8. doi: 10.1152/ajpendo.00064.2004. Epub 2004 Aug 31. PMID: 15339742.
  13. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22. PMID: 26707365.
  14. Qi YM, Xiao EH. Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosis. World J Gastroenterol. 2023 Jul 28;29(28):4384-4396. doi: 10.3748/wjg.v29.i28.4384. PMID: 37576700; PMCID: PMC10415971.
  15. Abbate M, Mascaró CM, Montemayor S, Casares M, Gómez C, Ugarriza L, Tejada S, Abete I, Zulet MA, Sureda A, Martínez JA, Tur JA. Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome. J Clin Med. 2021 Apr 16;10(8):1717. doi: 10.3390/jcm10081717. PMID: 33923418; PMCID: PMC8073467.
  16. Raubenheimer PJ, Nyirenda MJ, Walker BR. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes. 2006 Jul;55(7):2015-20. doi: 10.2337/db06-0097. PMID: 16804070.
  17. Yu D, Shu XO, Xiang YB, Li H, Yang G, Gao YT, Zheng W, Zhang X. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J Nutr. 2014 Dec;144(12):2034-40. doi: 10.3945/jn.114.197533. Epub 2014 Oct 15. PMID: 25320186; PMCID: PMC4230213.
  18. Fischer LM, daCosta KA, Kwock L, Stewart PW, Lu TS, Stabler SP, Allen RH, Zeisel SH. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr. 2007 May;85(5):1275-85. doi: 10.1093/ajcn/85.5.1275. PMID: 17490963; PMCID: PMC2435503.
  19. Młodzik-Czyżewska M, Malinowska A, Chmurzyńska A. Associations between choline intake, body composition, lipid profile, and liver status in healthy adults. Proc Nutr Soc. 2020;79(OCE2). doi:10.1017/s0029665120003195.
  20. Chai C, Chen L, Deng MG, Liang Y, Liu F, Nie JQ. Dietary choline intake and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2017-2018. Eur J Clin Nutr. 2023 Dec;77(12):1160-1166. doi: 10.1038/s41430-023-01336-1. Epub 2023 Aug 26. PMID: 37634048.
  21. Lăpădat AM, Florescu LM, Manea NC, Gheonea DI, Pirici D, Tudoraşcu DR, Ene R, Gheonea IA. MR spectroscopy of the liver - a reliable non-invasive alternative for evaluating non-alcoholic fatty liver disease. Rom J Morphol Embryol. 2020;61(1):73-80. doi: 10.47162/RJME.61.1.08. PMID: 32747897; PMCID: PMC7728118.
  22. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev. 2009 Nov;67(11):615-23. doi: 10.1111/j.1753-4887.2009.00246.x. PMID: 19906248; PMCID: PMC2782876.
  23. Xu L, Liu B, Huang Y, Liu X, Zhang SW, Xin XG, Zheng JZ. 3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline. World J Gastroenterol. 2013 Mar 7;19(9):1472-7. doi: 10.3748/wjg.v19.i9.1472. PMID: 23539666; PMCID: PMC3602508.
  24. Müller C, Hübner F, Bisdas S, Herzog C, Hammerstingl RM, Ackermann H, Vorbuchner M, Vogl TJ. In-vivo-Protonenspektroskopie des Leberparenchyms: Technik und Ergebnisse [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results]. Rofo. 2006 Nov;178(11):1128-36. German. doi: 10.1055/s-2006-927136. PMID: 17128381.
  25. Qayyum A. MR spectroscopy of the liver: principles and clinical applications. Radiographics. 2009 Oct;29(6):1653-64. doi: 10.1148/rg.296095520. PMID: 19959513; PMCID: PMC6939847.
  26. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23. PMID: 28545937.
  27. Chang TY, Wu CH, Chang CY, Lee FJ, Wang BW, Doong JY, Lin YS, Kuo CS, Huang RS. Optimal Dietary Intake Composition of Choline and Betaine Is Associated with Minimized Visceral Obesity-Related Hepatic Steatosis in a Case-Control Study. Nutrients. 2022 Jan 8;14(2):261. doi: 10.3390/nu14020261. PMID: 35057441; PMCID: PMC8779168.
  28. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010 Feb;51(2):679-89. doi: 10.1002/hep.23280. PMID: 20041406; PMCID: PMC3575093.
  29. Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9. PMID: 30414863.
  30. Zeisel SH. Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis. Clin Chem Lab Med. 2013 Mar 1;51(3):467-75. doi: 10.1515/cclm-2012-0518. PMID: 23072856; PMCID: PMC3624053.
  31. Nakamura T, Nakamura S, Karoji N, Aikawa T, Suzuki O. Hepatic function tests in heavy drinkers among workmen. Tohoku J Exp Med. 1967 Nov;93(3):219-26. doi: 10.1620/tjem.93.219. PMID: 5587662.
  32. Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: Definition and subtypes. Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28. PMID: 36577427; PMCID: PMC10029964.
  33. Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Adv Nutr. 2016 Jan 15;7(1):5-13. doi: 10.3945/an.114.007955. PMID: 26773011; PMCID: PMC4717871.
  34. Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int. 2008 Mar;28(3):297-307. doi: 10.1111/j.1478-3231.2007.01647.x. PMID: 18290772.
  35. Di Martino M, Pacifico L, Bezzi M, Di Miscio R, Sacconi B, Chiesa C, Catalano C. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol. 2016 Oct 21;22(39):8812-8819. doi: 10.3748/wjg.v22.i39.8812. PMID: 27818597; PMCID: PMC5075556.
  36. Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology. 2018 Aug;68(2):763-772. doi: 10.1002/hep.29797. PMID: 29356032; PMCID: PMC6054824.
  37. Jones JG. Non-Invasive Analysis of Human Liver Metabolism by Magnetic Resonance Spectroscopy. Metabolites. 2021 Oct 29;11(11):751. doi: 10.3390/metabo11110751. PMID: 34822409; PMCID: PMC8623827.

Download Article
Received May 10, 2024.
Accepted June 19, 2024.
©2024 International Medical Research and Development Corporation.